Revolution's pancreatic cancer drug breakthrough
The report framed the FDA approval of Revolution Medicines' pancreatic cancer drug Razonq as a major breakthrough, the first therapy to target a mutation driving a third of human cancers.
Keep reading this one
You've read the thesis and who argued it. A free account opens the argument, what validates it, the risks the show raised, and the moment in the episode where it was said — 3 ideas in full a day, no card.